This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chazal, N Articles by Boulanger, P Search for Related Content PubMed PubMed Citation Articles by Chazal, N Articles by Boulanger, P

 Previous Article  |  Next Article 

J Virol. 1994 January; 68(1): 111-122

Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.

Laboratoire de Virologie and Pathogénèse Moléculaires (CNRS URA 1487), Faculté de Médecine, Institut de Biologie, Montpellier, France.

ABSTRACT

A panel of 28 insertion mutants of the human immunodeficiency virus type 1 (HIV-1) Gag precursor (Pr55Gag) was constructed by linker-insertion mutagenesis and expressed in recombinant baculovirus-infected insect cells. One set of 14 mutants carried the normal N-myristylation signal; the other set constituted their non-N-myristylated counterparts. The mutants were characterized with respect to (i) assembly and extracellular release of membrane-enveloped budding Gag particles, (ii) intracellular assembly and nuclear transport of Gag cores, (iii) specific processing of Pr55Gag by HIV-1 protease in vivo, and (iv) binding of Pr55Gag to an HIV-1 genomic RNA probe in Northwestern blotting. Insertions within the region between amino acid residues 209 and 334 in the CA domain appeared to be the most detrimental to Gag particle assembly and release of Gag into the external medium, whereas a narrower window, between residues 209 and 241, was found to be critical for secretion of soluble Pr55Gag. Differences in Pr55Gag processing in vivo and RNA binding in vitro between N-myristylated and non-N-myristylated Gag mutants suggested a major conformational role for the myristylated N terminus of Gag precursor. In coinfection experiments using wild-type Gag- and mutant Gag-expressing recombinants, a transdominant negative effect on Gag particle assembly and release was observed for insertions located in two separate domains, the matrix and nucleocapsid.

This article has been cited by other articles:

• Li, H., Dou, J., Ding, L., Spearman, P. (2007). Myristoylation Is Required for Human Immunodeficiency Virus Type 1 Gag-Gag Multimerization in Mammalian Cells. J. Virol. 81: 12899-12910 [Abstract] [Full Text]  
• Fu, W., Dang, Q., Nagashima, K., Freed, E. O., Pathak, V. K., Hu, W.-S. (2006). Effects of Gag Mutation and Processing on Retroviral Dimeric RNA Maturation. J. Virol. 80: 1242-1249 [Abstract] [Full Text]  
• Ono, A., Waheed, A. A., Joshi, A., Freed, E. O. (2005). Association of Human Immunodeficiency Virus Type 1 Gag with Membrane Does Not Require Highly Basic Sequences in the Nucleocapsid: Use of a Novel Gag Multimerization Assay. J. Virol. 79: 14131-14140 [Abstract] [Full Text]  
• Roldan, A., Warren, O. U., Russell, R. S., Liang, C., Wainberg, M. A. (2005). A HIV-1 Minimal Gag Protein Is Superior to Nucleocapsid at in Vitro Annealing and Exhibits Multimerization-induced Inhibition of Reverse Transcription. J. Biol. Chem. 280: 17488-17496 [Abstract] [Full Text]  
• Roldan, A., Russell, R. S., Marchand, B., Gotte, M., Liang, C., Wainberg, M. A. (2004). In Vitro Identification and Characterization of an Early Complex Linking HIV-1 Genomic RNA Recognition and Pr55Gag Multimerization. J. Biol. Chem. 279: 39886-39894 [Abstract] [Full Text]  
• Teysset, L., Dang, V.-D., Kim, M. K., Levin, H. L. (2003). A Long Terminal Repeat-Containing Retrotransposon of Schizosaccharomyces pombe Expresses a Gag-Like Protein That Assembles into Virus-Like Particles Which Mediate Reverse Transcription. J. Virol. 77: 5451-5463 [Abstract] [Full Text]  
• Hoglund, S., Su, J., Reneby, S. S., Vegvari, A., Hjerten, S., Sintorn, I.-M., Foster, H., Wu, Y.-P., Nystrom, I., Vahlne, A. (2002). Tripeptide Interference with Human Immunodeficiency Virus Type 1 Morphogenesis. Antimicrob. Agents Chemother. 46: 3597-3605 [Abstract] [Full Text]  
• Liang, C., Hu, J., Russell, R. S., Roldan, A., Kleiman, L., Wainberg, M. A. (2002). Characterization of a Putative {alpha}-Helix across the Capsid-SP1 Boundary That Is Critical for the Multimerization of Human Immunodeficiency Virus Type 1 Gag. J. Virol. 76: 11729-11737 [Abstract] [Full Text]  
• Bardy, M., Gay, B., Pebernard, S., Chazal, N., Courcoul, M., Vigne, R., Decroly, E., Boulanger, P. (2001). Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing. J. Gen. Virol. 82: 2719-2733 [Abstract] [Full Text]  
• Burniston, M. T., Cimarelli, A., Colgan, J., Curtis, S. P., Luban, J. (1999). Human Immunodeficiency Virus Type 1 Gag Polyprotein Multimerization Requires the Nucleocapsid Domain and RNA and Is Promoted by the Capsid-Dimer Interface and the Basic Region of Matrix Protein. J. Virol. 73: 8527-8540 [Abstract] [Full Text]  
• Simon, J. H. M., Carpenter, E. A., Fouchier, R. A. M., Malim, M. H. (1999). Vif and the p55Gag Polyprotein of Human Immunodeficiency Virus Type 1 Are Present in Colocalizing Membrane-Free Cytoplasmic Complexes. J. Virol. 73: 2667-2674 [Abstract] [Full Text]  
• Campbell, S., Rein, A. (1999). In Vitro Assembly Properties of Human Immunodeficiency Virus Type 1 Gag Protein Lacking the p6 Domain. J. Virol. 73: 2270-2279 [Abstract] [Full Text]  
• Garnier, L., Parent, L. J., Rovinski, B., Cao, S.-X., Wills, J. W. (1999). Identification of Retroviral Late Domains as Determinants of Particle Size. J. Virol. 73: 2309-2320 [Abstract] [Full Text]  
• Peytavi, R., Hong, S. S., Gay, B., d'Angeac, A. D., Selig, L., Benichou, S., Benarous, R., Boulanger, P. (1999). HEED, the Product of the Human Homolog of the Murine eed Gene, Binds to the Matrix Protein of HIV-1. J. Biol. Chem. 274: 1635-1645 [Abstract] [Full Text]  
• Wang, C.-T., Lai, H.-Y., Li, J.-J. (1998). Analysis of Minimal Human Immunodeficiency Virus Type 1 gag Coding Sequences Capable of Virus-Like Particle Assembly and Release. J. Virol. 72: 7950-7959 [Abstract] [Full Text]  
• Morikawa, Y., Zhang, W.-H., Hockley, D. J., Nermut, M. V., Jones, I. M. (1998). Detection of a Trimeric Human Immunodeficiency Virus Type 1 Gag Intermediate Is Dependent on Sequences in the Matrix Protein, p17. J. Virol. 72: 7659-7663 [Abstract] [Full Text]  
• Garnier, L., Ratner, L., Rovinski, B., Cao, S.-X., Wills, J. W. (1998). Particle Size Determinants in the Human Immunodeficiency Virus Type 1 Gag Protein. J. Virol. 72: 4667-4677 [Abstract] [Full Text]  
• Krishna, N. K., Campbell, S., Vogt, V. M., Wills, J. W. (1998). Genetic Determinants of Rous Sarcoma Virus Particle Size. J. Virol. 72: 564-577 [Abstract] [Full Text]  
• Morikawa, Y., Hinata, S., Tomoda, H., Goto, T., Nakai, M., Aizawa, C., Tanaka, H., mura, S. (1996). Complete Inhibition of Human Immunodeficiency Virus Gag Myristoylation Is Necessary for Inhibition of Particle Budding. J. Biol. Chem. 271: 2868-2873 [Abstract] [Full Text]